backtop


Print 10 comment(s) - last by YashBudini.. on Jul 27 at 11:45 PM


  (Source: Nanotech Companies)
Researchers developed a safe way to deliver arsenic through the bloodstream

Researchers at Northwestern University combined a drug therapy, which is effective against blood cancers but not solid tumors, with nanotechnology and the end result was a combatant of a powerful type of breast cancer that is most common in young, African-American women.

This aggressive cancer, called triple negative breast cancer, cannot be treated by any sort of life-saving therapies or traditional chemotherapy. More often than not, women with triple negative breast cancer have a low chance of survival.

The drug therapy, arsenic trioxide, which is now commonly used by Western oncologists for certain types of leukemia, is not effective against solid tumors on its own because it is excreted too quickly after being injected into the bloodstream for it to work. The amount if arsenic trioxide injected into the body cannot be increased either, due to its toxicity. 

But now, researchers have combined the arsenic trioxide with a nanoparticle called a nanobin, which travels undetected after entering the bloodstream until it reaches the tumor and "attacks" it directly. The nanobin contains nanoparticulate arsenic trioxide embedded within a liposome (a tiny, thick vessel), and is cloaked in a chemical that both extends the nanobin's life and prohibits other cells from seeing it as it passes through the bloodstream. In addition, exposure of the toxic drug to normal normal tissue as it moves through the bloodstream is limited, and when the nanobin reaches the blood vessel of the tumor, the arsenic nanoparticles are released and buried in the abnormal cells of the tumor.

Richard Ahn, a student in the medical scientists training program at Northwestern, along with Vince Cryns, associate professor of medicine and an endocrinologist at Northwestern Medicine, and Tom O'Halloran, director of the Chemistry of Life Processes Institute at Northwestern, have all authored a research paper on the nanobin, which was published in Clinical Cancer Research on July 15. 

The nanobin was first tested on mice that contained triple negative breast cancer tumors. Some mice received the nanobin while others received regular arsenic trioxide therapy. The nanobin proved to decrease tumor growth while arsenic trioxide alone was not effective at all.

"The anti-tumor effects of the arsenic nanobins against clinically aggressive triple negative breast tumors in mice are extremely encouraging," said Cryns. "There's an urgent need to develop new therapies for poor prognosis triple negative breast cancer."

The development of this arsenic nanoparticle has opened the door to many other opportunities, such as making other existing cancer drugs, which have been set to the side due to their level of toxicity or because they're excreted too quickly, more effective in cancer tumor treatment. Researchers are now looking to improve the nanotechnology associated with cancer treatment by "decorating the nanobins with antibodies that recognize markers on tumor cells to increase the drug's uptake by the tumor." They'd also like to find a way to deliver two drugs within the same liposome to the tumor.

"Everyone said you can't use arsenic for solid tumors," saidO'Halloran. "That's because they didn't deliver it the right way. This new technology delivered the drug directly to the tumor, maintained its stability and shielded normal cells from the toxicity. That's huge."



Comments     Threshold


This article is over a month old, voting and posting comments is disabled

RE: Really??
By JEEPMON on 7/17/2010 2:15:11 AM , Rating: 2
First let me say congrats!
We do need a new way to deliver drugs to specific cells and the ongoing research of using nano-particles and liposomes is encouraging, but now they must go the next step. It will take decades though.
These are the stages:
First develop the drugs to destroy or permanently incapacitate the enemy cell (old school been doing that since germ theory)
Next find a way to deliver it better to the cell (ie. nano-particles/liposomes)
Next; recognize the altered DNA of the stem cell that caused the problem in the first place and permanently repair it.
Lastly develop techniques to detect immediately the DNA changes in cells the cause the harmful effects before they become systemic and/or symptomatic and possibly use vaccines as a preventative.
These new delivery methods will be old hat in the next 10 years and will greatly improve our treatment of all diseases but gene therapy and manipulation is the last most difficult step in the process to immortality.
Lets get moving!
FOCUS!


"Well, there may be a reason why they call them 'Mac' trucks! Windows machines will not be trucks." -- Microsoft CEO Steve Ballmer














botimage
Copyright 2014 DailyTech LLC. - RSS Feed | Advertise | About Us | Ethics | FAQ | Terms, Conditions & Privacy Information | Kristopher Kubicki